Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6
NCT00222547 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 720000
Last updated 2005-10-28
Summary
Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.
Conditions
- Village Children
Interventions
- DRUG
-
Vitamin A
- DRUG
-
Albendazole
Sponsors & Collaborators
-
United States Agency for International Development (USAID)
collaborator FED -
University of Oxford
lead OTHER
Principal Investigators
-
Shally Awasthi, MD · King George Medical University, Lucknow
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 1 Year
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-01-31
- Completion
- 2005-02-28
Countries
- India
Study Locations
More Related Trials
-
The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
NCT01314937 ·Status: COMPLETED ·Phase: PHASE4
-
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
NCT01379326 ·Status: COMPLETED ·Phase: PHASE4
-
Relative Efficacy of Two Regimens of Ante-helminthic Treatment
NCT00367627 ·Status: COMPLETED ·Phase: NA
-
A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia
NCT01146496 ·Status: COMPLETED ·Phase: NA
-
Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
NCT01658774 ·Status: COMPLETED ·Phase: NA
-
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance
NCT03465488 ·Status: COMPLETED ·Phase: NA
-
Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule
NCT00602056 ·Status: COMPLETED ·Phase: NA
-
Assessment of Drug Efficacy of Local Albendazole
NCT02420574 ·Status: COMPLETED ·Phase: NA
-
A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial
NCT00374023 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition
NCT01395381 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants
NCT02034162 ·Status: COMPLETED ·Phase: PHASE3
-
Cotrimoxazole Prophylaxis in Severely Malnourished Children
NCT00934492 ·Status: COMPLETED ·Phase: PHASE3
-
Severe Anemia Treatment Trials, Pakistan
NCT00116493 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IVM/ALB Co-administration
NCT03527732 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Triple Combinations Against Hookworm Infections in Lao
NCT03278431 ·Status: COMPLETED ·Phase: PHASE4
-
Package of Interventions After Recovering From Moderate Acute Malnutrition
NCT02351687 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
NCT00207753 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
NCT06720259 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
NCT02234570 ·Status: COMPLETED ·Phase: PHASE1
-
Albendazole Dose Finding and Pharmacokinetics in Children and Adults
NCT03527745 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
NCT02636803 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Bangladesh Environmental Enteric Dysfunction Study
NCT02812615 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
NCT03435718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh
NCT00607074 ·Status: COMPLETED ·Phase: NA
-
PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets
NCT04920292 ·Status: COMPLETED ·Phase: PHASE1